FY4/24 3Q
Supplementary Materials

March 1, 2024

１．Consolidated Results■Year-on-Year(¥ million)

FY4/23 3Q
results

FY4/24 3Q
results

Net sales

263,906

296,360+32,454+12.3

Gross profit

39,692

43,213+3,521+8.9% of net sales

15.0

14.6

28,00628,907

+901

+3.2

10.6

9.8

11,685

14,305+2,620

+22.4

4.4

4.8

12,367

15,050+2,683

+21.7

4.7

5.1

6,628

8,730

+2,102+31.7% of net sales

2.5

2.9

Earnings pershare(¥)

188.70248.51+59.81+31.7

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributableto owners of parent

YoYchange

YoYchange(%)

Figures in the table are rounded down

■Vs Plan(¥ million)

FY4/24 3Q
plan

FY4/24 3Q
results

Net sales

292,551

296,360+3,809+1.3

Gross profit

42,721

43,213+492+1.2% of net sales

14.6

14.6

29,45328,907

(546)

(1.9)

10.1

9.8

13,26814,305+1,037

+7.8

4.5

4.8

14,03815,050+1,012

+7.2

4.8

5.1

7,609

8,730

+1,121+14.7% of net sales

2.6

2.9

Earnings pershare(¥)

216.60248.51+31.91+14.7

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributableto owners of parent

Figures in the table are rounded down

-1-Vs planchange

Vs planchange(%)

２. Segment Information（Dispensing Pharmacy Business）■Year-on-Year(¥ million)

FY4/23 3Q
results

FY4/24 3Q
results

Net sales

236,396

265,019+28,623+12.1

Gross profit

29,44831,508+2,060+7.0% of net sales

12.5

11.9

12,067

12,551+484+4.0

5.1

4.7

17,38018,957+1,577+9.1

7.4

7.2

18,023

19,713+1,690

+9.4

7.6

7.4

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

YoYchangeYoYchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the quarterly consolidated statement of income■Vs Plan(¥ million)

FY4/24 3Q
plan

FY4/24 3Q
results

Net sales

261,480

265,019+3,539+1.4

Gross profit

31,08831,508+420+1.4% of net sales

11.9

11.9

12,59812,551(47)

(0.4)

4.8

4.7

18,49018,957+467

+2.5

7.1

7.2

19,214

19,713+499+2.6

7.3

7.4

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

Vs planchange

Vs planchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the quarterly consolidated statement of income-2-

3. Segment Information（Cosmetic and Drug Store Business）■Year-on-Year(¥ million)

FY4/23 3Q
results

FY4/24 3Qresults

Net sales

18,83622,905+4,069+21.6

Gross profit

7,102

8,800+1,698+23.9% of net sales

37.7

38.4

6,4016,588+187+2.9% of net sales

34.0

28.8

Operating profit

700

2,212+1,512+216.0% of net sales

3.7

9.7

Segment profit

737

2,246+1,509+204.7% of net sales

3.9

9.8

SG&A expenses

YoYchangeYoYchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the quarterly consolidated statement of income■Vs Plan(¥ million)

FY4/24 3Qplan

FY4/24 3Q
results

Net sales

22,42022,905+485+2.2

Gross profit

8,540

8,800+260+3.0% of net sales

38.1

38.4

6,590

6,588(2)

0.0

29.4

28.8

1,950

2,212+262+13.4

8.7

9.7

1,958

2,246+288+14.7

8.7

9.8

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

Vs planchange

Vs planchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the quarterly consolidated statement of income-3-4. Sales Verification■Dispensing Pharmacy Business (YoY）■Dispensing Pharmacy Business（Vs Plan）

Net sales

Net sales（%）

Average
Prescription
prescription
volume（%）
price

Average
Prescription
prescription
volumeprice

Same store (1,064)＋7.5＋6.3＋1.2

Same store (1,064)＋1.7＋1.0＋0.7

Store openings in theprevious year (133)＋66.3＋57.1＋6.6

Store openings in theprevious year (133)＋2.8＋1.4＋1.6

Total (1,221)＋12.3＋10.2＋2.0

Total (1,221)＋1.4＋0.7＋0.7■Cosmetic and Drug Store Business（YoY）■Cosmetic and Drug Store Business (Vs Plan）

Net sales

Net sales（%）

Average
Number ofspending per
customers
customer（%）

Average
Number ofspending per
customers
customerSame store (68)＋22.5＋12.5＋8.9

Same store (68)＋0.4(4.2)＋4.8Store openings in theprevious year (8)＋156.8＋152.8＋1.6

Store openings in theprevious year (8)＋9.8＋5.3＋4.3

＋21.6

＋12.9

＋7.7

Total (81)

＋2.2

(3.6)

＋6.0

Total (81)-4-

5. Consolidated Balance Sheet■Assets(¥ million)

End-FY4/23 3Q

End-FY4/23

End-FY4/24 3Q

Change46,193
11,26923,62995,49020,591
10,584

46,796
13,24921,58698,305
21,407
10,60250,057
14,00727,093
106,837
27,010
10,116+3,261+758+5,507+8,532+5,603(486)

38,51939,45942,745+3,28647,53953,1102,938
6,118
24,82346,44352,343
2,720
5,990
24,50743,94750,664
3,427
6,287
24,713(2,496)(1,679)+707+297+206

42,44341,64143,440+1,799Total assets

134,072
229,562

133,444
231,750

136,850
243,688+3,406+11,938

Figures in the table are rounded down

Change: End-FY4/24 3Q compared with end-FY4/23

Cash on hand and in banks
Accounts receivable
Inventories
Total current assets
Buildings and structures, net
Land
Total property, plant andequipment
Goodwill
Total intangible fixed assets
Investments in securities
Deferred tax assets
Deposits and guarantees
Total investments and otherassets
Total fixed assets

Capital expenditures(Purchases of property, plant and equipment and intangible fixed assets + Deposits and guarantees)
totaled ¥10,447million■Liabilities and Net Assets

End-FY4/23 3Q

End-FY4/23

End-FY4/24 3Q

ChangeTotal liabilities and net assets

60,972
4,036
92,823
5,816
12,995
105,819
21,89420,504
83,357
123,756
123,743
229,562

58,6983,670
92,986
5,021
12,218105,204
21,89420,50485,963
126,362
126,546
231,750

67,987
3,183
100,847
2,366
9,561
110,409
21,894
20,49992,586
132,997
133,278
243,688+9,289(487)+7,861(2,655)(2,657)+5,205(5)+6,623+6,635+6,732+11,938

Figures in the table are rounded down

Change: End-FY4/24 3Q compared with end-FY4/23(¥ million)
Accounts payable
Short-term debt
Total current liabilities
Long-term debt
Total long-term liabilities
Total liabilities
Common stock
Capital surplus
Retained earnings
Total shareholders’ equity
Total net assets-5-6. FY4/24 Plan (Consolidated)(¥ million)

FY4/23
results

FY4/24
initial plan

FY4/24
revised plan

YoYchange（%）

Vs initialplan change（%）

Net sales

358,742

375,000

390,263+8.8+4.1

Gross profit

53,69855,413

58,106＋8.2

＋4.9

15.0

14.8

14.9

37,69439,750

39,656＋5.2(0.2)

10.5

10.6

10.2

16,004

15,66318,450

+15.3

＋17.8

4.5

4.2

4.7

17,06416,302

19,340

+13.3

＋18.6

4.8

4.3

5.0

Profit attributableto owners of parent

9,234

8,250

10,000

+8.3

＋21.2

% of net sales

2.6

2.2

2.6

Earnings pershare(¥)

262.87234.84284.64

+8.3

＋21.2

Annual dividend (¥)

60.00

60.00

60.00

0.0

0.0

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Figures in the table are rounded down-6-7. Transition of Store Openings■Number of Store Openings in Dispensing Pharmacy Business
FY4/16 FY4/17 FY4/18 FY4/19 FY4/20 FY4/21 FY4/22 FY4/23

FY4/243QOrganic

322725231415252714M&A

110

182

11134

61424114

11Total

881

1,066

1,029

1,132

1,088

1,065

1,099

1,2091,221■Number of Store Openings in Cosmetic and Drug Store Business
FY4/16 FY4/17 FY4/18 FY4/19 FY4/20 FY4/21 FY4/22 FY4/23

FY4/243QOrganic

594715111285Total

525248546369787881

Inquiries related to this presentation should be addressed toAIN HOLDINGS INC.
Corporate Planning Division
TEL(81)11-814-0010
FAX(81)11-814-5550
https://www.ainj.co.jp/corporate/
This document may not be reproduced or distributed to any third party without
prior approval of AIN HOLDINGS INC. This document has been prepared for
information purpose only and does not form part of a solicitation to sell orpurchase any securities. Information contained herein may be changed orrevised without prior notice. This document may contain forecasting statements
as to future results of operations. No forecast statement can be guaranteed andactual results of operations may differ from those projected.

-7-